Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 25

1.

[The results of five years follow-up prospective study of vaginal prolapse repaired by prolift total mesh surgery or sacrospinous fixation].

Kraus P, Krofta L, Krčmář M, Urbánková I, Gojiš O, Grogregin K, Feyereisl J.

Ceska Gynekol. 2017 Fall;82(4):277-286. Czech.

PMID:
28925271
2.

[Reconstruction of the posterior and central compartment with the Prolift Posterior: cohort study with a 5-year follow-up].

Brányik K, Krofta L, Kraus P, Krčmář M, Gojiš O, Urbánková I, Feyereisl J.

Ceska Gynekol. 2017 Fall;82(4):268-276. Czech.

PMID:
28925270
3.

SRC3 Phosphorylation at Serine 543 Is a Positive Independent Prognostic Factor in ER-Positive Breast Cancer.

Zwart W, Flach KD, Rudraraju B, Abdel-Fatah TM, Gojis O, Canisius S, Moore D, Nevedomskaya E, Opdam M, Droog M, Hofland I, Chan S, Shaw J, Ellis IO, Coombes RC, Carroll JS, Ali S, Palmieri C.

Clin Cancer Res. 2016 Jan 15;22(2):479-91. doi: 10.1158/1078-0432.CCR-14-3277. Epub 2015 Sep 14.

4.

Neoadjuvant chemotherapy and trastuzumab versus neoadjuvant chemotherapy followed by post-operative trastuzumab for patients with HER2-positive breast cancer.

Palmieri C, Macpherson IR, Yan K, Ades F, Riddle P, Ahmed R, Owadally W, Stanley B, Shah D, Gojis O, Januszewski A, Lewanski C, Asher R, Lythgoe D, de Azambuja E, Beresford M, Howell SJ.

Oncotarget. 2016 Mar 15;7(11):13209-20. doi: 10.18632/oncotarget.4801.

5.

Expression of selected proteins in breast cancer brain metastases.

Gojis O, Kubecova M, Rosina J, Vranova J, Celko M, Frajerova D, Zmrhal J, Zahumensky J, Bacova T, Baca V, Mandys V, Kucera E.

Folia Histochem Cytobiol. 2013;51(3):213-8. doi: 10.5603/FHC.2013.0030.

6.

[The injury of bladder without penetrate during the TVT surgery for stress incontinence].

Popelka J, Zmrhal J, Gojiš O.

Ceska Gynekol. 2013 Aug;78(4):356-9. Czech.

PMID:
24040984
7.

[Cooperation between mammologist and radiodiagnostic in the management of mammary leasions in the University Hospital Kralovské Vinohrady].

Bendová M, Malina R, Gojiš O, Večeřová L, Zemanová G.

Ceska Gynekol. 2013 Aug;78(4):333-7. Review. Czech.

PMID:
24040979
8.

Velamentous insertion of the umbilical cord of twin B as a cause of vasa previa in monochorionic diamniotic twins.

Zahumensky J, Gojis O, Kiss I, Kucera E.

Int J Gynaecol Obstet. 2013 Sep;122(3):261-2. doi: 10.1016/j.ijgo.2013.04.011. Epub 2013 Jun 21. No abstract available.

PMID:
23796258
9.

Expression of steroid receptor coactivator 3 in ovarian epithelial cancer is a poor prognostic factor and a marker for platinum resistance.

Palmieri C, Gojis O, Rudraraju B, Stamp-Vincent C, Wilson D, Langdon S, Gourley C, Faratian D.

Br J Cancer. 2013 May 28;108(10):2039-44. doi: 10.1038/bjc.2013.199. Epub 2013 May 7.

10.

Site-specific CpG methylation in the CCAAT/enhancer binding protein delta (CEBPδ) CpG island in breast cancer is associated with metastatic relapse.

Palmieri C, Monteverde M, Lattanzio L, Gojis O, Rudraraju B, Fortunato M, Syed N, Thompson A, Garrone O, Merlano M, Lo Nigro C, Crook T.

Br J Cancer. 2012 Aug 7;107(4):732-8. doi: 10.1038/bjc.2012.308. Epub 2012 Jul 10.

11.

[Reproductive functions in women after cancer therapy].

Záhumenský J, Feldmár P, Kučera E, Zmrhal J, Gojiš O, Kosová T, Bendová M, Stejskal D.

Klin Onkol. 2012;25(3):173-7. Review. Czech.

PMID:
22724565
12.

NT5E CpG island methylation is a favourable breast cancer biomarker.

Lo Nigro C, Monteverde M, Lee S, Lattanzio L, Vivenza D, Comino A, Syed N, McHugh A, Wang H, Proby C, Garrone O, Merlano M, Hatzimichael E, Briasoulis E, Gojis O, Palmieri C, Jordan L, Quinlan P, Thompson A, Crook T.

Br J Cancer. 2012 Jun 26;107(1):75-83. doi: 10.1038/bjc.2012.212. Epub 2012 May 31.

13.

Methylation of the calcium channel regulatory subunit α2δ-3 (CACNA2D3) predicts site-specific relapse in oestrogen receptor-positive primary breast carcinomas.

Palmieri C, Rudraraju B, Monteverde M, Lattanzio L, Gojis O, Brizio R, Garrone O, Merlano M, Syed N, Lo Nigro C, Crook T.

Br J Cancer. 2012 Jul 10;107(2):375-81. doi: 10.1038/bjc.2012.231. Epub 2012 May 29.

14.

Differential oestrogen receptor binding is associated with clinical outcome in breast cancer.

Ross-Innes CS, Stark R, Teschendorff AE, Holmes KA, Ali HR, Dunning MJ, Brown GD, Gojis O, Ellis IO, Green AR, Ali S, Chin SF, Palmieri C, Caldas C, Carroll JS.

Nature. 2012 Jan 4;481(7381):389-93. doi: 10.1038/nature10730.

15.

High frequency of complex TP53 mutations in CNS metastases from breast cancer.

Lo Nigro C, Vivenza D, Monteverde M, Lattanzio L, Gojis O, Garrone O, Comino A, Merlano M, Quinlan PR, Syed N, Purdie CA, Thompson A, Palmieri C, Crook T.

Br J Cancer. 2012 Jan 17;106(2):397-404. doi: 10.1038/bjc.2011.464. Epub 2011 Dec 20.

16.

Human epidermal growth factor receptor 2-positive breast cancer relapsing post-adjuvant trastuzumab: pattern of recurrence, treatment and outcome.

Krell J, James CR, Shah D, Gojis O, Lim A, Riddle P, Ahmad R, Makris A, Cowdray A, Chow A, Babayev T, Madden P, Leonard R, Cleator S, Palmieri C.

Clin Breast Cancer. 2011 Jun;11(3):153-60. doi: 10.1016/j.clbc.2011.03.012. Epub 2011 Apr 20.

PMID:
21665135
17.

Management and outcome of HER2-positive early breast cancer treated with or without trastuzumab in the adjuvant trastuzumab era.

Palmieri C, Shah D, Krell J, Gojis O, Hogben K, Riddle P, Ahmad R, Tat T, Fox K, Porter A, Mahmoud S, Kirschke S, Shousha S, Gudi M, Coombes RC, Leonard R, Cleator S.

Clin Breast Cancer. 2011 Apr;11(2):93-102. doi: 10.1016/j.clbc.2011.03.001. Epub 2011 Apr 11.

PMID:
21569995
18.

The role of SRC-3 in human breast cancer.

Gojis O, Rudraraju B, Gudi M, Hogben K, Sousha S, Coombes RC, Cleator S, Palmieri C.

Nat Rev Clin Oncol. 2010 Feb;7(2):83-9. doi: 10.1038/nrclinonc.2009.219. Epub 2009 Dec 22. Review. Erratum in: Nat Rev Clin Oncol. 2010 Mar;7(3):122. Coombes, Charles R [corrected to Coombes, R Charles].

PMID:
20027190
19.

Poor reception?

Alifrangis C, Harcourt JP, Gojis O, Palmieri C.

Lancet. 2009 Sep 12;374(9693):948. doi: 10.1016/S0140-6736(09)61120-X. No abstract available.

PMID:
19748400
20.

An unusual triple-negative breast carcinoma.

Shousha S, Peston D, Gojis O, Palmieri C.

Histopathology. 2009 Sep;55(3):364-6. doi: 10.1111/j.1365-2559.2009.03349.x. No abstract available.

PMID:
19723156

Supplemental Content

Loading ...
Support Center